ReviewMolecular and cellular biochemistry2026
Ubiquitin's code: UPS orchestrating DNA repair and genomic stability under genotoxic stress.
Review in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The genetic blueprint of life faces ongoing threats from physical and chemical agents that can disrupt DNA and lead to genomic instability, which is one of the hallmarks of cancer. These agents include external factors like ionizing radiation, UV radiation, radiotherapy, and chemotherapeutic drugs or internal factors like redox imbalance arising from deregulated cellular metabolism. These agents damage DNA by generating inter-strand crosslinks, DNA-protein crosslinks, bulky adducts or double-strand breaks that ultimately decreases genomic integrity and leads to tumorigenesis. The coordinated actions of E3 ubiquitin ligases and deubiquitinases (DUBs) are essential in the precise control of these DNA damage tolerance and repair pathways. This has unravelled vulnerable points for intervention in cancer chemoresistance, since it has been observed that these ubiquitinases and deubiquitinases may upregulate repair proteins that reverses DNA damage conferred by conventional chemotherapeutics. This review focusses on the intricate dynamics of ubiquitination and deubiquitination in controlling DNA damage repair pathways and safeguarding genomic integrity.
Indexed as
Identifiers
42118426What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.